Show simple item record

dc.rights.licenseopenen_US
hal.structure.identifierImmunology from Concept and Experiments to Translation [ImmunoConcept]
dc.contributor.authorKAMINSKI, Hannah
dc.contributor.authorMÉNARD, Coline
hal.structure.identifierImmunology from Concept and Experiments to Translation [ImmunoConcept]
dc.contributor.authorEL HAYANI, Bouchra
dc.contributor.authorADJIBABI, And-Nan
hal.structure.identifierImmunology from Concept and Experiments to Translation [ImmunoConcept]
dc.contributor.authorMARSERES, Gabriel
dc.contributor.authorCOURANT, Maxime
hal.structure.identifierImmunology from Concept and Experiments to Translation [ImmunoConcept]
dc.contributor.authorZOUINE, Atika
hal.structure.identifierImmunology from Concept and Experiments to Translation [ImmunoConcept]
dc.contributor.authorPITARD, Vincent
dc.contributor.authorGARRIGUE, Isabelle
IDREF: 12258953X
dc.contributor.authorBURREL, Sonia
hal.structure.identifierImmunology from Concept and Experiments to Translation [ImmunoConcept]
dc.contributor.authorMOREAU, Jean-François
hal.structure.identifierImmunology from Concept and Experiments to Translation [ImmunoConcept]
dc.contributor.authorCOUZI, Lionel
hal.structure.identifierImmunology from Concept and Experiments to Translation [ImmunoConcept]
dc.contributor.authorVISENTIN, Jonathan
hal.structure.identifierImmunology from Concept and Experiments to Translation [ImmunoConcept]
dc.contributor.authorMERVILLE, Pierre
hal.structure.identifierImmunology from Concept and Experiments to Translation [ImmunoConcept]
dc.contributor.authorDÉCHANET-MERVILLE, Julie
dc.date.accessioned2021-12-01T09:12:29Z
dc.date.available2021-12-01T09:12:29Z
dc.date.issued2021-02-24
dc.identifier.issn1537-6613en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/123953
dc.description.abstractEnCytomegalovirus (CMV) is a major infectious cause of death and disease after transplantation. We have previously demonstrated that the tissue-associated adaptive Vδ2neg γδ T cells are key effectors responding to CMV and associated with recovery, contrasting with their innatelike circulating counterparts, the Vγ9posVδ2pos T cells that respond to phosphoantigens but not to CMV. A third Vγ9negVδ2pos subgroup with adaptive functions has been described in adults. In the current study, we demonstrate that these Vγ9negVδ2pos T cells are also components of the CMV immune response while presenting with distinct characteristics from Vδ2neg γδ T cells. In a cohort of kidney transplant recipients, CMV seropositivity was the unique clinical parameter associated with Vγ9negVδ2pos T-cell expansion and differentiation. Extensive phenotyping demonstrated their substantial cytotoxic potential and activation during acute CMV primary infection or reinfection. In vitro, Vγ9negVδ2pos T cells responded specifically to CMV-infected cells in a T-cell receptor-dependent manner and through strong interferon γ production. Finally, Vγ9negVδ2pos T cells were the only γδ T-cell subset in which expansion was tightly correlated with the severity of CMV disease. To conclude, our results identify a new player in the immune response against CMV and open interesting clinical perspectives for using Vγ9negVδ2pos T cells as an immune marker for CMV disease severity in immunocompromised patients.
dc.language.isoENen_US
dc.subject.enBiomarkers
dc.subject.enCell Line
dc.subject.enCytomegalovirus
dc.subject.enCytomegalovirus Infections
dc.subject.enFemale
dc.subject.enFibroblasts
dc.subject.enHumans
dc.subject.enImmunocompromised Host
dc.subject.enInterferon-gamma
dc.subject.enKidney Transplantation
dc.subject.enLymphocyte Activation
dc.subject.enMale
dc.subject.enMiddle Aged
dc.subject.enReceptors
dc.subject.enAntigen
dc.subject.enT-Cell
dc.subject.engamma-delta
dc.subject.enSeverity of Illness Index
dc.subject.enT-Lymphocyte Subsets
dc.title.enCharacterization of a Unique γδ T-Cell Subset as a Specific Marker of Cytomegalovirus Infection Severity.
dc.title.alternativeJ Infect Disen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1093/infdis/jiaa400en_US
dc.subject.halSciences du Vivant [q-bio]/Immunologieen_US
dc.identifier.pubmed32622351en_US
bordeaux.journalJournal of Infectious Diseasesen_US
bordeaux.page655-666en_US
bordeaux.volume223en_US
bordeaux.hal.laboratoriesImmunoConcEpT - UMR 5164en_US
bordeaux.issue4en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionCNRSen_US
bordeaux.institutionCHU de Bordeauxen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.identifierhal-03460730
hal.version1
hal.date.transferred2021-12-01T09:14:43Z
hal.exporttrue
workflow.import.sourcepubmed
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20Infectious%20Diseases&rft.date=2021-02-24&rft.volume=223&rft.issue=4&rft.spage=655-666&rft.epage=655-666&rft.eissn=1537-6613&rft.issn=1537-6613&rft.au=KAMINSKI,%20Hannah&M%C3%89NARD,%20Coline&EL%20HAYANI,%20Bouchra&ADJIBABI,%20And-Nan&MARSERES,%20Gabriel&rft.genre=article


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record